IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 238 filers reported holding IMMUNOGEN INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3 | -99.9% | 631 | 0.0% | 0.00% | – |
Q3 2022 | $3,000 | +50.0% | 631 | +39.3% | 0.00% | – |
Q2 2022 | $2,000 | -66.7% | 453 | -68.7% | 0.00% | – |
Q1 2022 | $6,000 | -33.3% | 1,446 | +15.3% | 0.00% | – |
Q4 2021 | $9,000 | +350.0% | 1,254 | +151.8% | 0.00% | – |
Q3 2021 | $2,000 | -50.0% | 498 | -25.2% | 0.00% | – |
Q2 2021 | $4,000 | -20.0% | 666 | +5.5% | 0.00% | – |
Q1 2021 | $5,000 | +150.0% | 631 | +66.9% | 0.00% | – |
Q4 2020 | $2,000 | +100.0% | 378 | -5.3% | 0.00% | – |
Q3 2020 | $1,000 | -50.0% | 399 | -0.7% | 0.00% | – |
Q2 2020 | $2,000 | +100.0% | 402 | +1.5% | 0.00% | – |
Q1 2020 | $1,000 | -75.0% | 396 | -49.3% | 0.00% | – |
Q4 2019 | $4,000 | +100.0% | 781 | -12.2% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 890 | -10.2% | 0.00% | – |
Q2 2019 | $2,000 | -87.5% | 991 | -82.9% | 0.00% | – |
Q1 2019 | $16,000 | – | 5,808 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |